Next generation sequencing Market Analysis

1. Next generation sequencing (NGS) Market Analysis and Future Scope 2021 The Next generation sequencing (NGS) marketplace is expected to grow at a CAGR of 16.2% from 2019 to reach $10.35 billion by means of 2025. Increase of the Next generation sequencing marketplace is majorly driven by way of growth in genome mapping programs; makemakeup in packages of subsequent technology sequencing; increase in healthcare expenditure; and technological improvements in sequencing systems. as an instance, in 2019, Thermo Fisher medical, a international leader in serving science, released Ion Torrent Genexus gadget that's a subsequent technology platform that make-upplymakeup the specimen to record in just a single day. moreover, in 2019, Agilent technologies, Inc., an American analytical improvement and production organization, released Magnis NGS Prep device, a subsequent era sequencing library coaching device that's designed to run the complicated sequencing assays in a press of a button. The genetic b6fd8d88d79ed1018df623d0b49e84e7 and configuration of the fetus may be detected thru NGS-orientated tests inclusive of non-invasive prenatal checking out (NIPT), and pre-implantation genetic trying out (PGT). The R&D associated with NGS has been escalating to new heights via extra funding in NGS technologies at some stage in the world. Surge in demand for genome mapping application and rise in application of NGS boosts the boom of the marketplace. Based on kind, the worldwide NGS services marketplace is segmented into focused sequencing services, complete-genome sequencing offerings, RNA sequencing services, exome sequencing offerings, de novo sequencing services, ChIP sequencing offerings, methyl sequencing offerings, and different NGS services. In 2021, the centered sequencing services segment is expected to account for the biggest share of the global NGS offerings marketplace. The big share of this section may be attributed to the notably decrease fee, quicker turnaround time, and accurate, clean-to-interpret outcomes of targeted sequencing within the examine of ailment-related genes. Primarily based on era, the worldwide NGS offerings market is segmented into sequencing through synthesis (SBS), ion semiconductor sequencing (IOS), unmarried-molecule real-time sequencing (SMRT), nanopore sequencing, and other NGS technology. In 2021, the sequencing by means of synthesis (SBS) segment is predicted to account for the most important percentage of the worldwide NGS services market. This large share of this phase is attributed to its maximum yield of error-loose throughput, base name price above Q30, and better accuracy in DNA sequencing compared to different sequencing technologies available in the marketplace. Based on application, the global NGS offerings market is segmented into biomarker discovery, diagnostics, drug discovery, agriculture & animal research, and other programs. In 2021, the diagnostics section is predicted to account for the biggest proportion of the worldwide NGS services market. This phase's massive share is in particular attributed to the giant use of NGS services in most cancers diagnostics globally and makemakeup in NGS-based oncology and non-invasive prenatal assessments (NIPT). developing emphasis on making use of NGS in most cancers studies fuels the boom of this market. Key players operating within the global next-generation sequencing services marketplace are Illumina, Inc. (U.S.), Qiagen N.V. (Netherland), PerkinElmer, Inc. (U.S.), Eurofins clinical S.E. (Luxembourg), Macrogen, Inc. (South Korea), LGC confined (U.ok.), GENEWIZ, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), SciGenom Labs Pvt. Ltd (India), MedGenome Inc. (U.S.), DNA hyperlink, Inc. (South Korea), Otogenetics organization (U.S.), Novogene Co., Ltd. (China), CD Genomics (U.S.), basis medicinal drug, Inc. (U.S) and SeqLL, Inc. (U.S.).

2. COVID-19 impact on the worldwide next-era Sequencing market COVID-19 is an infectious disease as a result of the most recently observed novel coronavirus. in large part unknown before the outbreak started out in Wuhan (China) in December 2019, COVID-19 has moved from being a local disaster to a international pandemic. With the world fitness organisation (WHO) officially declared the outbreak of COVID-19 a virulent disease, a combination of installed pharmaceutical and biopharmaceutical gromakemakeup, in conjunction with predominant gamers and smaller start-united stateswithin the NGS marketplace, have stepped forward to contribute to worldwide research efforts of developing take a look at kits, treatments, and vaccines. organizations have scaled make-up R&D efforts to expand vaccines and pills against the virus. for instance, researchers at Fuyang city (China) were the first to series COVID-19 samples the usage of Oxford Nanopore technologies (uk) MinION Mk1C. The team is a part of a growing community of public fitness and CDC labs in China that are deploying Nanopore merchandise for fast epidemiological surveillance. In February, Nanopore deployed 2 hundred MinIONs to China, and lots of these are now in use for viral and bacterial sequencing surveillance programs. Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research